Jazz Pharmaceuticals (JAZZ) Treasury Shares (2012 - 2025)

Jazz Pharmaceuticals' Treasury Shares history runs 14 years deep, the most recent figure standing at $4.4 million for Q4 2025.

• In Q4 2025, Treasury Shares rose 9.25% year-over-year to $4.4 million; the TTM figure through Dec 2025 stood at $4.4 million (up 9.25% YoY), while the FY2025 annual figure was $4.4 million, up 9.25% from the prior year.
• Treasury Shares was $4.4 million for Q4 2025 at Jazz Pharmaceuticals, up from $4.0 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $4.4 million in Q4 2025 to a low of $214000.0 in Q4 2021.
• Historically, Treasury Shares has averaged $2.1 million across 5 years, with a median of $1.5 million in 2024.
• The sharpest annual moves came in 2021 and 2022: Treasury Shares tumbled 88.6% in 2021, then soared 1399.53% in 2022.
• A 5-year view of Treasury Shares shows it stood at $214000.0 in 2021, then jumped by 1399.53% to $3.2 million in 2022, then tumbled by 34.56% to $2.1 million in 2023, then soared by 92.05% to $4.0 million in 2024, then increased by 9.25% to $4.4 million in 2025.
• The last three Treasury Shares figures came in at $4.4 million (Q4 2025), $4.0 million (Q4 2024), and $1.4 million (Q3 2024), per Business Quant data.